The National Cancer Institute’s (NCI) Clinical Trials Cooperative Group Plan has played a important function in creating new and improved cancer therapies. Nonetheless, the plan is falling short of its potential, and the IOM recommends modifications that aim to transform the Cooperative Group Plan into a dynamic program that effectively responds to emerging scientific information involves broad cooperation of stakeholders and leverages evolving technologies to offer high-quality, practice-modifying resea
List Price: $ 5.95
Price: [wpramaprice asin=”B0043M67HQ”]
Leave a Reply
You must be logged in to post a comment.